Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
2(13%)
Results Posted
20%(1 trials)
Terminated
1(7%)

Phase Distribution

Ph phase_1
1
7%
Ph phase_4
1
7%
Ph not_applicable
10
67%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
1(8.3%)
Phase 4Post-market surveillance
1(8.3%)
N/ANon-phased studies
10(83.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

71.4%

5 of 7 finished

Non-Completion Rate

28.6%

2 ended early

Currently Active

2

trials recruiting

Total Trials

15

all time

Status Distribution
Active(4)
Completed(5)
Terminated(2)
Other(4)

Detailed Status

Completed5
unknown4
Not yet recruiting2
Withdrawn1
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
15
Active
2
Success Rate
83.3%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (8.3%)
Phase 41 (8.3%)
N/A10 (83.3%)

Trials by Status

withdrawn17%
completed533%
recruiting17%
unknown427%
not_yet_recruiting213%
terminated17%
active_not_recruiting17%

Recent Activity

Clinical Trials (15)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
15